Progress of lymphocyte activation gene 3 and programmed cell death protein 1 antibodies for cancer treatment: A review. Biomol Biomed [Internet]. 2024 Apr. 6 [cited 2026 Jan. 28];24(4):764-7. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10339